Use of Elores™ in Guiding Successful Treatment of Ventilator Associated Pneumonia Due to Multi Drug Resistant Acinetobacter baumannii and Klebsiella pneumoniae
Ashish Gupta *
Max Super Specialty Hospital, Mohali, India
Sunny Rupal
Max Super Specialty Hospital, Mohali, India
*Author to whom correspondence should be addressed.
Abstract
Introduction: Increased antimicrobial resistance of Acinetobacter baumannii (A. baumannii) and Klebsiella pneumoniae (K. pneumoniae), is of great concern worldwide. Management of Ventilator associated pneumonia (VAP) due to MDR poses a challenge for clinicians.
Case Presentation: Here we are discussing a case of 47 year old male patient diagnosed with VAP due to A. baumannii and K. pneumoniae. Use of Elores™ (Ceftriaxone/Sulbactam/Disodium-edetate) as antibiotic for the treatment of VAP due to MDR pathogen K. pneumoniae and A. baumannii resulted in clinical cure of infection.
Conclusion: Elores™ can be considered as a safe and efficacious antibiotic to treat MDR gram negative pathogens in VAP.
Keywords: Ceftriaxone/Sulbactam/Disodium-edetate, antibiotic resistance, Acinetobacter baumannii, Klebsiella pneumoniae, CSE1034, ventilator associated pneumonia (VAP).